What Can Improvement Look Like?1,3,4,8,9
Improved Endoscopic Outcomes in a Bio-Naïve Clinical Trial Patient
- Patient Profile: Age: 40's
- Sex: Female
- Disease Severity: Moderate to Severe
- Disease Duration: 2.1 Years
- Drug History: Bio-Naïve
Patient received SKYRIZI 600 mg IV (Induction) and 180 mg SC (Maintenance)
Patient Case Study Representing Remission AT WEEKS 12 AND 52
THIS IMAGE REPRESENTS AN INDIVIDUAL PATIENT WHO WAS TREATED WITH SKYRIZI WHO HAD ENDOSCOPIC REMISSION AT WEEK 52. IN THE FORTIFY MAINTENANCE CLINICAL TRIAL, ENDOSCOPIC REMISSION DATA AT WEEK 52 WAS NOT STATISTICALLY SIGNIFICANT UNDER THE
PRE-SPECIFIED MULTIPLE TESTING PROCEDURE.
IMAGES ARE FROM A CLINICAL TRIAL PATIENT TREATED WITH SKYRIZI. INDIVIDUAL RESULTS MAY VARY.
What Can Improvement Look Like?1,3,7,8
Improved Endoscopic Outcomes in a Biologic Failure Clinical Trial Patient
- Patient Profile: Age: 30’s
- Sex: Male
- Disease Severity: Severe
- Disease Duration: 3.4 Years
- Drug History: Has Failed One Prior Biologic
Patient received SKYRIZI 600 mg IV (Induction) and 360 mg SC (Maintenance)
Patient Case Study Representing Response and/or Remission at Weeks 12 and 52
THIS IMAGE REPRESENTS AN INDIVIDUAL PATIENT WHO WAS TREATED WITH SKYRIZI WHO HAD ENDOSCOPIC REMISSION AT WEEK 52. IN THE FORTIFY MAINTENANCE CLINICAL TRIAL, ENDOSCOPIC REMISSION DATA AT WEEK 52 WAS NOT STATISTICALLY SIGNIFICANT UNDER THE
PRE-SPECIFIED MULTIPLE TESTING PROCEDURE.
IMAGES ARE FROM A CLINICAL TRIAL PATIENT TREATED WITH SKYRIZI. INDIVIDUAL RESULTS MAY VARY.